Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)A Study of Keluo Xin Capsule Compare to Placebo in Terms of Efficacy and Safety in Patients With Diabetic Retinopathy
Phase 2
- Conditions
- Moderately Severe to Severe NPDR
- Interventions
- Drug: Keluo Xin capsuleDrug: Placebo oral capsule
- First Posted Date
- 2017-08-23
- Last Posted Date
- 2017-08-24
- Lead Sponsor
- Chengdu Kanghong Pharmaceutical Co., Ltd.
- Target Recruit Count
- 198
- Registration Number
- NCT03258242
News
No news found